DNA sequencing fragment analysis reagents
Ended Awarded
- Contract number
- HHSN26311453
- Awardee
-
Applied Biosystems, LLC UEI NZ18DJLAEDS1 Part of Life Technologies Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,190
Award facts
- Contract value <1% obligated
-
- $5,592,096.00 Current, with exercised options
- $11,807,850.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6850 Miscellaneous Chemical Specialties
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Maryland, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
About this award
Applied Biosystems, LLC, a subsidiary of Life Technologies Corporation (Thermo Fisher Scientific), received a delivery order contract award on January 26, 2005, valued at $11.8 million for DNA sequencing fragment analysis reagents. The contract, which operates under a Firm Fixed Price structure with no set-aside designation, is scheduled for completion by May 31, 2005, with performance taking place in Maryland. This award supports the federal government's genetic analysis and sequencing capabilities, providing essential laboratory reagents and consumables for DNA fragment analysis across multiple federal agencies engaged in research, forensic analysis, and environmental initiatives.
Life Technologies Corporation is a well-established provider of biotechnology products and scientific instruments to federal agencies including the National Institutes of Health, Department of Defense, Centers for Disease Control and Prevention, and federal law enforcement. The company's extensive portfolio includes genetic analyzers, real-time polymerase chain reaction systems, DNA sequencers, and associated reagent kits. The delivery order mechanism under this contract enables efficient procurement of specialized genetic analysis reagents, supporting the ongoing research and diagnostic missions of federal agencies requiring advanced molecular biology tools and consumables.
Quick answers
Who was awarded contract HHSN26311453?
HHSN26311453 was awarded to Applied Biosystems, LLC by Office of the Director (National Institutes of Health) on January 26, 2005.
How much is contract HHSN26311453 worth?
The government has obligated $8,190 on HHSN26311453. Its current value, with exercised options, is $5,592,096. Its potential value, with all options, is $11,807,850.
Is contract HHSN26311453 an order under another contract?
Yes. HHSN26311453 is a delivery order under HHSN263200000025, an indefinite delivery contract.
Was contract HHSN26311453 competed?
The extent of competition for HHSN26311453 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award